Original articles
Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta-analysis with sub-group analysis of potential prognostic factors
Marcio Barcellosa,b,1, Antonio Bragaa,b,c,1,
, Matheus Machado Rechd, Solange Artimos de Oliveirab, Jose Mauro Madid, Sue Yazaki Sune, Jorge de Rezende-Filhoa, Kevin M. Eliasf, Neil S. Horowitzf, Ross S. Berkowitzf
Corresponding author
a Centro de Doenças Trofoblásticas do Rio de Janeiro, Maternidade Escola da Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
b Postgraduate Program in Medical Sciences, Faculdade de Medicina, Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil
c Postgraduate Program in Applied Health Sciences, Universidade de Vassouras, Vassouras, RJ, Brazil
d Centro de Doenças Trofoblásticas de Caxias do Sul, Faculdade de Medicina, Universidade de Caxias do Sul, Caxias do Sul, RS, Brazil
e Department of Obstetrics, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
f New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA